2/8
08:11 am
adpt
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]
2/8
02:04 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) was upgraded by analysts at
Wall
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) was upgraded by analysts at
Wall
2/6
03:51 pm
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $21.00. They now have an "overweight" rating on the stock.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $21.00. They now have an "overweight" rating on the stock.
2/6
10:08 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at TD Cowen.
2/6
08:03 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.
Medium
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $22.00 price target on the stock, up previously from $21.00.
2/6
08:02 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) was given a new $21.00 price target on by analysts at Piper Sandler.
Medium
Report
Adaptive Biotechnologies (NASDAQ:ADPT) was given a new $21.00 price target on by analysts at Piper Sandler.
2/5
08:16 pm
adpt
Adaptive Biotechnologies Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Adaptive Biotechnologies Q4 Earnings Call Highlights [Yahoo! Finance]
2/5
05:00 pm
adpt
Adaptive Biotechnologies: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Adaptive Biotechnologies: Q4 Earnings Snapshot [Yahoo! Finance]
2/5
04:18 pm
adpt
Adaptive Biotechnologies GAAP EPS of -$0.09 beats by $0.09, revenue of $71.7M beats by $10.8M [Seeking Alpha]
Medium
Report
Adaptive Biotechnologies GAAP EPS of -$0.09 beats by $0.09, revenue of $71.7M beats by $10.8M [Seeking Alpha]
2/5
04:05 pm
adpt
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
1/27
04:05 pm
adpt
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
Medium
Report
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
1/26
10:59 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/23
12:05 am
adpt
Refractory Follicular Lymphoma Diagnostics Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 [Yahoo! Finance]
Low
Report
Refractory Follicular Lymphoma Diagnostics Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 [Yahoo! Finance]
1/22
04:05 pm
adpt
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
Low
Report
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
1/12
09:16 pm
adpt
Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 [Yahoo! Finance]
1/12
07:30 am
adpt
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
High
Report
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
1/7
10:58 am
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/30
04:05 pm
adpt
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/26
09:24 am
adpt
Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle [Seeking Alpha]
Low
Report
Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle [Seeking Alpha]
12/15
08:10 am
adpt
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer [Yahoo! Finance]
12/15
08:00 am
adpt
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
Low
Report
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
12/9
05:53 pm
adpt
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease [Yahoo! Finance]
Medium
Report
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease [Yahoo! Finance]
12/9
05:07 pm
adpt
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
Medium
Report
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
12/6
08:30 am
adpt
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
Low
Report
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
12/3
10:26 pm
adpt
Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback [Yahoo! Finance]
Low
Report
Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback [Yahoo! Finance]